DHR
Price
$269.23
Change
-$0.00 (-0.00%)
Updated
Oct 9 closing price
12 days until earnings call
RGEN
Price
$136.55
Change
-$0.00 (-0.00%)
Updated
Oct 9 closing price
19 days until earnings call
Ad is loading...

DHR vs RGEN

Header iconDHR vs RGEN Comparison
Open Charts DHR vs RGENBanner chart's image
Danaher
Price$269.23
Change-$0.00 (-0.00%)
Volume$1.51M
CapitalizationN/A
Repligen
Price$136.55
Change-$0.00 (-0.00%)
Volume$297.66K
CapitalizationN/A
View a ticker or compare two or three
DHR vs RGEN Comparison Chart
Loading...
DHR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RGEN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
DHR vs. RGEN commentary
Oct 11, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DHR is a StrongBuy and RGEN is a StrongSell.

COMPARISON
Comparison
Oct 11, 2024
Stock price -- (DHR: $269.23 vs. RGEN: $136.54)
Brand notoriety: DHR and RGEN are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: DHR: 70% vs. RGEN: 30%
Market capitalization -- DHR: $184.93B vs. RGEN: $10.26B
DHR [@Medical Specialties] is valued at $184.93B. RGEN’s [@Medical Specialties] market capitalization is $10.26B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DHR’s FA Score shows that 2 FA rating(s) are green whileRGEN’s FA Score has 1 green FA rating(s).

  • DHR’s FA Score: 2 green, 3 red.
  • RGEN’s FA Score: 1 green, 4 red.
According to our system of comparison, DHR is a better buy in the long-term than RGEN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DHR’s TA Score shows that 4 TA indicator(s) are bullish while RGEN’s TA Score has 2 bullish TA indicator(s).

  • DHR’s TA Score: 4 bullish, 4 bearish.
  • RGEN’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, DHR is a better buy in the short-term than RGEN.

Price Growth

DHR (@Medical Specialties) experienced а -1.71% price change this week, while RGEN (@Medical Specialties) price change was -4.67% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -2.01%. For the same industry, the average monthly price growth was +3.93%, and the average quarterly price growth was -2.96%.

Reported Earning Dates

DHR is expected to report earnings on Feb 04, 2025.

RGEN is expected to report earnings on Feb 19, 2025.

Industries' Descriptions

@Medical Specialties (-2.01% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DHR($185B) has a higher market cap than RGEN($10.3B). RGEN has higher P/E ratio than DHR: RGEN (247.52) vs DHR (43.86). DHR YTD gains are higher at: 16.744 vs. RGEN (-24.060). DHR has higher annual earnings (EBITDA): 7.5B vs. RGEN (134M). DHR has more cash in the bank: 5.86B vs. RGEN (751M). RGEN has less debt than DHR: RGEN (712M) vs DHR (19.5B). DHR has higher revenues than RGEN: DHR (23.9B) vs RGEN (639M).
DHRRGENDHR / RGEN
Capitalization185B10.3B1,796%
EBITDA7.5B134M5,594%
Gain YTD16.744-24.060-70%
P/E Ratio43.86247.5218%
Revenue23.9B639M3,740%
Total Cash5.86B751M781%
Total Debt19.5B712M2,739%
FUNDAMENTALS RATINGS
DHR vs RGEN: Fundamental Ratings
DHR
RGEN
OUTLOOK RATING
1..100
6556
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
93
Overvalued
PROFIT vs RISK RATING
1..100
2270
SMR RATING
1..100
7689
PRICE GROWTH RATING
1..100
3462
P/E GROWTH RATING
1..100
121
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

DHR's Valuation (69) in the Medical Specialties industry is in the same range as RGEN (93) in the Biotechnology industry. This means that DHR’s stock grew similarly to RGEN’s over the last 12 months.

DHR's Profit vs Risk Rating (22) in the Medical Specialties industry is somewhat better than the same rating for RGEN (70) in the Biotechnology industry. This means that DHR’s stock grew somewhat faster than RGEN’s over the last 12 months.

DHR's SMR Rating (76) in the Medical Specialties industry is in the same range as RGEN (89) in the Biotechnology industry. This means that DHR’s stock grew similarly to RGEN’s over the last 12 months.

DHR's Price Growth Rating (34) in the Medical Specialties industry is in the same range as RGEN (62) in the Biotechnology industry. This means that DHR’s stock grew similarly to RGEN’s over the last 12 months.

RGEN's P/E Growth Rating (1) in the Biotechnology industry is in the same range as DHR (12) in the Medical Specialties industry. This means that RGEN’s stock grew similarly to DHR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DHRRGEN
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
65%
Bullish Trend 2 days ago
78%
Momentum
ODDS (%)
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
68%
MACD
ODDS (%)
Bearish Trend 2 days ago
58%
Bearish Trend 2 days ago
69%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
58%
Bearish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
57%
Bearish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 2 days ago
62%
Bullish Trend 22 days ago
78%
Declines
ODDS (%)
Bearish Trend 4 days ago
54%
Bearish Trend 3 days ago
77%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
50%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
57%
Bearish Trend 2 days ago
68%
View a ticker or compare two or three
Ad is loading...
DHR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RGEN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL229.543.77
+1.67%
Apple
SPY577.143.97
+0.69%
SPDR® S&P 500® ETF Trust
GME20.50-0.21
-1.01%
GameStop Corp
TSLA241.05-3.45
-1.41%
Tesla
BTC.X60582.100000-1549.867200
-2.49%
Bitcoin cryptocurrency

RGEN and

Correlation & Price change

A.I.dvisor indicates that over the last year, RGEN has been loosely correlated with DHR. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if RGEN jumps, then DHR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RGEN
1D Price
Change %
RGEN100%
+1.13%
DHR - RGEN
65%
Loosely correlated
+0.16%
TMO - RGEN
57%
Loosely correlated
+0.64%
WAT - RGEN
54%
Loosely correlated
-0.58%
CRL - RGEN
53%
Loosely correlated
+0.47%
A - RGEN
53%
Loosely correlated
+0.13%
More